Table 1 Clinical and treatment characteristics of prostate cancer cases
From: Geographic and outcome variation among black men diagnosed with prostate cancer
Characteristic | US-born Brooklyn N = 125 N (%) | African-born Brooklyn N = 37 N (%) | Caribbean-born Brooklyn N = 406 N (%) | Caribbean-born Trinidad &Tobago N = 1,594 N (%) | P-Value |
|---|---|---|---|---|---|
Histology | Â | Â | Â | Â | Â |
Carcinoma, NOS | 4 (3.2) | 2 (5.4) | 5 (1.2) | 177 (11.1) | <0.0001 |
Adenocarcinoma | 121 (96.8) | 35 (94.6) | 397 (97.8) | 1,406 (88.2) | Â |
Other1 | 0 (0.0) | 0 (0.0) | 4 (0.99) | 11 (0.7) | Â |
Stage | Â | Â | Â | Â | Â |
I-III | 111 (88.8) | 32 (86.5) | 367 (90.4) | 953 (59.8) | <0.0001 |
IV | 12 (9.6) | 3 (8.1) | 27 (6.7) | 338 (21.2) | Â |
Unstaged | 2 (1.6) | 2 (5.4) | 12 (3.0) | 303(19.0) | Â |
Treatment | Â | Â | Â | Â | Â |
Stage I-III | N = 111 | N = 32 | N = 367 | N = 953 | <0.0001 |
No treatment | 32 (28.8) | 9 (28.1) | 54 (14.7) | 250 (26.2) | Â |
Surgery only | 34 (30.6) | 10 (31.2) | 128 (34.9) | 107 (11.2) | Â |
Radiotherapy only | 29 (26.1) | 5 (15.6) | 83 (22.6) | 64 (6.7) | Â |
Hormone therapy only | 0 (0.0) | 0 (0.0) | 13 (3.5) | 295 (31.0) | Â |
Combination therapy* | 16 (14.4) | 8 (25.0) | 89 (24.3) | 237 (24.9) | Â |
Treatment | Â | Â | Â | Â | Â |
Stage IV | N = 12 | N = 3 | N = 27 | N = 338 | 0.295 |
No treatment | 6 (50.0) | 1 (33.3) | 9 (33.3) | 124 (36.7) | Â |
Surgery only | 2 (16.7) | 0 (0.0) | 1 (3.7) | 13 (3.9) | Â |
Radiotherapy only | 2 (16.7) | 1 (33.3) | 2 (7.4) | 32 (9.5) | Â |
Hormone therapy only | 2 (16.7) | 1 (33.3) | 9 (33.3) | 74 (21.9) | Â |
Combination therapy* | 0 (0.0) | 0 (0.0) | 6 (22.2) | 95 (28.1) | Â |